PL EN


Preferences help
enabled [disable] Abstract
Number of results
2017 | 64 | 1 | 65-73
Article title

Is there a link between TNF gene expression and cognitive deficits in depression?

Content
Title variants
Languages of publication
EN
Abstracts
EN
Neuroinflammation is a known factor in the pathogenesis of recurrent depressive disorders. Depression is accompanied by activated immune-inflammatory pathways including increased levels of TNFα, sTNFR1and sTNFR2.The purpose of this study was to analyse the TNF-α, TNFRSF1A and TNFRSF1B genes on both mRNA and protein levels in patients with rDD, and to investigate the relationship between TNF-α,TNFRSF1A and TNFRSF1B gene expression and cognitive performance. The study comprised 158 subjects: patients with recurrent depressive disorder (n=89) and healthy subjects (n=69). Cognitive function assessment was based on: Trail Making Test, The Stroop Test, Verbal Fluency Test and Auditory Verbal Learning Test. Both mRNA and protein expression levels of all genes were significantly higher in rDD subjects when compared to healthy controls. No statistically significant correlations were observed between the analysed variables in both the rDD group and the HS test group. The only exception was noticed in the HS test group, where increased expression of TNFRSF1A and TNFRSF1B gene negatively affected the performance of the AVLT test. However, statistically significant correlations between TNF, TNFRSF1A, TNFRSF1B mRNA gene expression levels and all the neuropsychological tests used in the survey for the entire group were observed. Conclusions: 1.The results of our study show increased expression of the TNF, TNFRSF1A and TNFRSF1B genes on both mRNA and protein levels in depression. 2. Elevated expression of TNF-α, TNFRSF1A and TNFRSF1B negatively correlates with cognitive efficiency: working memory, executive functions, attention, auditory-verbal memory, effectiveness of learning processes and verbal fluency.
Publisher

Year
Volume
64
Issue
1
Pages
65-73
Physical description
Dates
published
2017
received
2016-02-22
revised
2016-09-19
accepted
2016-11-16
(unknown)
2016-12-16
Contributors
  • Department of Adult Psychiatry, Medical University of Lodz, Łódź, Poland
  • Department of Pulmonology and Allergology, Medical University of Lodz, Łódź, Poland
  • Department of Medical Biochemistry, Medical University of Lodz, Łódź, Poland
  • Department of Adult Psychiatry, Medical University of Lodz, Łódź, Poland
  • Department of Adult Psychiatry, Medical University of Lodz, Łódź, Poland
References
  • Anisman H (2009) Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci 34: 4-20.
  • Becking K, Boschloo L, Vogelzangs N, Haarman BC, Riemersma-van der Lek R, Penninx BW, Schoevers RA (2013) The association between immune activation and manic symptoms in patients with a depressive disorder. Transl Psychiatry 3: e314. doi: 10.1038/tp.2013.87.
  • Besedovsky HO, del Rey A (2000) The cytokine-HPA axis feed-back circuit. Z Rheumatol 59 (Suppl 2): 26-30.
  • Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW (2011) Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol 29: 3517-3522. doi: 10.1200/JCO.2011.36.1154.
  • Butler MP, O'Connor JJ, Moynagh PN (2004) Dissection of tumor-necrosis factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early-but not late-phase LTP. Neuroscience 124: 319-26. doi: 10.1016/j.neuroscience.2003.11.040.
  • Christian LM, Glaser R, Porter K, Malarkey WB, Beversdorf D, Kiecolt-Glaser JK (2011) Poorer self-rated health is associated with elevated inflammatory markers among older adults. Psychoneuroendocrinology 36: 1495-1504. doi: 10.1016/j.psyneuen.2011.04.003.
  • Dahl J, Ormstad H, Aass HC, Sandvik L, Malt UF, Andreassen OA (2016) Recovery from major depressive disorder episode after non-pharmacological treatment is associated with normalized cytokine levels. Acta Psychiatr Scand 134: 40-47. doi: 10.1111/acps.12576.
  • Dannehl K, Rief W, Schwarz MJ, Hennings A, Riemer S, Selberdinger V, Stapf T, Euteneuer F (2014) The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression. Neuropsychiatr Dis Treat 10: 1191-1197. doi: 10.2147/NDT.S61640.
  • Dantzer R (2009) Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am 29: 247-264. doi: 10.1016/j.iac.2009.02.002.
  • Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9: 46-46. doi: 10.1038/nrn2297.
  • Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67: 446-447. doi: 10.1016/j.biopsych.2009.09.033.
  • Dummer W, Niethammer AG, Baccala R, Lawson BR, Wagner N, Reisfeld RA, Theofilopoulos AN (2002) T cell homeostatic proliferation elicits effective antitumor autoimmunity. J Clin Invest 110: 185-192. doi: 10.1172/JCI15175.
  • El-Tantawy AM, El-Sayed AE, Kora BA, Amin RT (2008) Psychiatric morbidity associated with some cytokines (IL-1beta, IL-12, IL-18 and TNF-alpha) among rheumatoid arthritis patients. Egypt J Immunol 15: 1-11.
  • Eyre H, Papps E, Baune BT (2013) Treating depression and depression-like behavior with physical activity: an immune perspective. Front Psychiatry 4: 3. doi: 10.3389/fpsyt.2013.00003.
  • Figueroa-Vega N, Moreno-Frías C, Malacara JM (2015) Alterations in adhesion molecules, pro-inflammatory cytokines and cell-derived microparticles contribute to intima-media thickness and symptoms in postmenopausal women. PLoS One 10: e0120990. doi: 10.1371/journal.pone.0120990.
  • Fontenelle LF, Barbosa IG, Luna JV, de Sousa LP, Abreu MN, Teixeira AL (2012) A cytokine study of adult patients with obsessive-compulsive disorder. Compr Psychiatry 53: 797-804. doi: 10.1016/j.comppsych.2011.12.007.
  • Gałecki P, Talarowska M (2016) The evolutionary theory of depression. Med Sci Monit (in press). doi: 10.12659/MSM.901240
  • Grosse L, Ambrée O, Jörgens S, Jawahar MC, Singhal G, Stacey D, Arolt V, Baune BT (2016) Cytokine levels in major depression are related to childhood trauma but not to recent stressors. Psychoneuroendocrinology 73: 24-31. doi: 10.1016/j.psyneuen.2016.07.205.
  • Hannestad J, DellaGioia N, Bloch M (2011) The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 36: 2452-2459. doi: 10.1038/npp.2011.132.
  • Himmerich H, Fischer J, Bauer K, Kirkby KC, Sack U, Krügel U (2013) Stress-induced cytokine changes in rats. Eur Cytokine Netw 24: 97-103. doi: 10.1684/ecn.2013.0338.
  • ICD-10 Classification of Mental & Behavioural Disorders (1993) World Health Organization, Genewa
  • Iosif RE, Ekdahl CT, Ahlenius H, Pronk CJ, Bonde S, Kokaia Z, Jacobsen SE, Lindvall O (2006) Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J Neurosci 26: 9703-9712. doi: 10.1523/JNEUROSCI.2723-06.2006.
  • Janelidze S, Mattei D, Westrin A, Traskman-Bendz L, Brundin L (2011) Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun 25: 335-339. doi: 10.1016/j.bbi.2010.10.010.
  • Jurgens HA, Amancherla K, Johnson RW (2012) Influenza infection induces neuroinflammation, alters hippocampal neuron morphology, and impairs cognition in adult mice. J Neurosci 32: 3958-3968. doi: 10.1523/JNEUROSCI.6389-11.2012.
  • Khairova RA, Machado-Vieira R, Du J, Manji HK (2009) A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol 12: 561-568. doi: 10.1017/S1461145709009924.
  • Khemka VK, Ganguly A, Bagchi D, Ghosh A, Bir A, Biswas A, Chattopadhyay S, Chakrabarti S (2014) Raised serum proinflammatory cytokines in Alzheimer's disease with depression. Aging Dis 5: 170-176. doi: 10.14336/AD.2014.0500170.
  • Kiecolt-Glaser JK, Gouin JP, Weng NP, Malarkey WB, Beversdorf DQ, Glaser R (2011) Childhood adversity heightens the impact of later-life caregiving stress on telomere length and inflammation. Psychosom Med 73: 16-22. doi: 10.1097/PSY.0b013e31820573b6.
  • Kirkwood B, Sterne J (2003) Essential medical statistics, 2nd edn. Wiley-Bleckwell. MEDLINE
  • Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H (2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22: 370-379. doi: 10.1016/S0893-133X(99)00134-7.
  • Lezak MD (2004) Neuropsychological Assessment. Oxford University Press, New York, Oxford. MEDLINE
  • Lichtblau N, Schmidt FM, Schumann R, Kirkby KC, Himmerich H (2013) Cytokines as biomarkers in depressive disorder: current standing and prospects. Int Rev Psychiatry 25: 592-603. doi: 10.3109/09540261.2013.813442.
  • Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. doi: 10.1006/meth.2001.1262.
  • Maes M, Bosmans E, Suy E, Vandervorst C, De Jonckheere C, Raus J (1990-1991) Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Neuropsychobiology 24: 115-120.
  • Maes M, Kubera M, Leunis JC, Berk M, Geffard M, Bosmans E (2013) In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes. Acta Psychiatr Scand 127: 344-354. doi: 10.1111/j.1600-0447.2012.01908.x.
  • Maes M, Twisk FN, Ringel K (2012) Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Psychother Psychosom 81: 286-295. doi: 10.1159/000336803.
  • Marin I, Kipnis J (2013) Learning and memory ... and the immune system. Learn Mem 20: 601-606. doi: 10.1101/lm.028357.112.
  • Michie HR, Spriggs DR, Manogue KR, Sherman ML, Revhaug A, O'Dwyer ST, Arthur K, Dinarello CA, Cerami A, Wolff SM (1988) Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 104: 280-286.
  • Mihailova S, Ivanova-Genova E, Lukanov T, Stoyanova V, Milanova V, Naumova E (2016) A study of TNF-α, TGF-β, IL-10, IL-6, and IFN-γ gene polymorphisms in patients with depression. J Neuroimmunol 293: 123-128. doi: 10.1016/j.jneuroim.2016.03.005.
  • Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M (2001) Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 11: 203-208.
  • Mills NT, Scott JG, Wray NR, Cohen-Woods S, Baune BT (2013) Research review: the role of cytokines in depression in adolescents: a systematic review. J Child Psychol Psychiatry 54: 816-815.
  • Moylan S, Berk M, Dean OM, Samuni Y, Williams LJ (2014) Oxidative & nitrosative stress in depression: why so much stress? Neurosci Biobehav Rev 45: 46-62. doi: 10.1016/j.neubiorev.2014.05.007.
  • Moylan S, Maes M, Wray NR, Berk M (2013) The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry 18: 595-606. doi: 10.1038/mp.2012.33.
  • Naude PJ, Dobos N, van der Meer D, Mulder C, Pawironadi KG, den Boer JA, van der Zee EA, Luiten PG, Eisel UL (2014) Analysis of cognition, motor performance and anxiety in young and aged tumor necrosis factor alpha receptor 1 and 2 deficient mice. Behav Brain Res 258: 43-51. doi: 10.1016/j.bbr.2013.10.006.
  • O'Brien SM, Scully P, Fitzgerald P, Scott LV, Dinan TG (2007) Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res 41: 326-331. doi: 10.1016/j.jpsychires.2006.05.013.
  • O'Donovan A, Rush G, Hoatam G, Hughes BM, McCrohan A, Kelleher C, O'Farrelly C, Malone KM (2013) Suicidal ideation is associated with elevated inflammation in patients with major depressive disorder. Depress Anxiety 30: 307-314. doi: 10.1002/da.22087.
  • Oliveira Miranda D, Soares de Lima TA, Ribeiro Azevedo L, Feres O, Ribeiro da Rocha JJ, Pereira-da-Silva G (2014) Proinflammatory cytokines correlate with depression and anxiety in colorectal cancer patients. Biomed Res Int 2014: 739650. doi: 10.1155/2014/739650.
  • Pandey GN, Rizavi HS, Ren X, Fareed J, Hoppensteadt DA, Roberts RC, Conley RR, Dwivedi Y (2012) Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. J Psychiatr Res 46: 57-63. doi: 10.1016/j.jpsychires.2011.08.006.
  • Park M, Newman LE, Gold PW, Luckenbaugh DA, Yuan P, Machado-Vieira R, Zarate CA Jr (2016) Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression. J Psychiatr Res 84: 113-118. doi: 10.1016/j.jpsychires.2016.09.025.
  • Patten S (1997) Performance of the Composite International Diagnostic Interview Short Form for major depression in community and clinical samples. Chronic Dis Can 18: 109-112.
  • Pickering M, O'Connor JJ (2007) Pro-inflammatory cytokines and their effects in the dentate gyrus. Prog Brain Res 163: 339-354. doi: 10.1016/S0079-6123(07)63020-9.
  • Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, Haroon E, Miller AH (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 70: 31-41. doi: 10.1001/2013.jamapsychiatry.4.
  • Schmidt FM, Lichtblau N, Minkwitz J, Chittka T, Thormann J, Kirkby KC, Sander C, Mergl R, Faßhauer M, Stumvoll M, Holdt LM, Teupser D, Hegerl U, Himmerich H (2014) Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity. J Psychiatr Res. 55: 29-34. doi: 10.1016/j.jpsychires.2014.04.021.
  • Schuld A, Schmid DA, Haack M, Holsboer F, Friess E, Pollmächer T (2003) Hypothalamo-pituitary-adrenal function in patients with depressive disorders is correlated with baseline cytokine levels, but not with cytokine responses to hydrocortisone. J Psychiatr Res 37: 463-70.
  • Serafini G, Pompili M, Elena Seretti M, Stefani H, Palermo M, Coryell W, Girardi P (2013) The role of inflammatory cytokines in suicidal behavior: a systematic review. Eur Neuropsychopharmacol 23: 1672-1686. doi: 10.1016/j.euroneuro.2013.06.002.
  • Silverman MN, Pearce BD, Biron CA, Miller AH (2005) Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol 18: 41-78. doi: 10.1089/vim.2005.18.41.
  • Simpson W, Steiner M, Coote M, Frey BN (2016) Relationship between inflammatory biomarkers and depressive symptoms during late pregnancy and the early postpartum period: a longitudinal study. Rev Bras Psiquiatr 38: 190-196. doi: 10.1590/1516-4446-2015-1899.
  • Singhal G, Jaehne EJ, Corrigan F, Toben C, Baune BT (2014) Inflammasomes in neuroinflammation and changes in brain function: a focused review. Front Neurosci 8: 315. doi: 10.3389/fnins.2014.00315.
  • Smagula SF, Lotrich FE, Aizenstein HJ, Diniz BS, Krystek J, Wu GF, Mulsant BH, Butters MA, Reynolds CF 3rd, Lenze EJ (2016) Immunological biomarkers associated with brain structure and executive function in late-life depression: exploratory pilot study. Int J Geriatr Psychiatry. 2016 Jun 10. [Epub ahead of print]. doi: 10.1002/gps.4512.
  • Stellwagen D, Malenka RC (2016) Synaptic scaling mediated by glial TNF-α. Nature 440: 1054-1059. doi: 10.1038/nature04671.
  • Sudheimer KD, O'Hara R, Spiegel D, Powers B, Kraemer HC, Neri E, Weiner M, Hardan A, Hallmayer J, Dhabhar FS (2014) Cortisol, cytokines, and hippocampal volume interactions in the elderly. Front Aging Neurosci 6: 153. doi: 10.3389/fnagi.2014.00153.
  • Szczepanska-Sadowska E, Cudnoch-Jedrzejewska A, Ufnal M, Zera T (2010) Brain and cardiovascular diseases: common neurogenic background of cardiovascular, metabolic and inflammatory diseases. J Physiol Pharmacol 61: 509-521.
  • Talarowska M, Bobińska K, Zajączkowska M, Su KP, Maes M, Gałecki P (2014) Impact of oxidative/nitrosative stress and inflammation on cognitive functions in patients with recurrent depressive disorders. Med Sci Monit 20: 110-115. doi: 10.12659/MSM.889853.
  • Talarowska M, Gałecki P, Maes M, Bobińska K, Kowalczyk E (2012) Total antioxidant status correlates with cognitive impairment in patients with recurrent depressive disorder. Neurochemical Research 37: 1761-1767. doi: 10.1007/s11064-012-0788-z.
  • Talarowska M, Szemraj J, Zajączkowska M, Gałecki P (2014b) ASMT gene expression correlates with cognitive impairment in patients with recurrent depressive disorder. Med Sci Monit 20: 905-912. doi: 10.12659/MSM.890160.
  • Talarowska M, Zboralski K, Gałecki P (2013) Correlations between working memory effectiveness and depression levels after pharmacological therapy. Psychiatr Pol 47: 255-267.
  • Winer J, Jung CK, Shackel I, Williams PM (1999) Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270: 41-49. doi: 10.1006/abio.1999.4085.
  • Young JJ, Bruno D, Pomara N (2014) A review of the relationship between proinflammatory cytokines and major depressive disorder. J Affect Disord 169: 15-20. doi: 10.1016/j.jad.2014.07.032.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.bwnjournal-article-abpv64p65kz
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.